Today's Information

Provided by: MAXIGEN BIOTECH INC.
SEQ_NO 1 Date of announcement 2022/08/09 Time of announcement 21:29:50
Subject 
 Monthly revenue report, July 2022
Date of events 2022/08/09 To which item it meets paragraph 51
Statement 
1.Date of occurrence of the event:2022/08/09
2.Company name:Maxigen Biotech Inc
3.Relationship to the Company (please enter "head office" or
  "subsidiaries"):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:N/A
6.Countermeasures:N/A
7.Any other matters that need to be specified:
Maxigen Biotech Inc. (TWSE: 1783) today announced its net revenues
for July 2022.
On a consolidated basis, revenues for July 2022 were
approximately NT$ 46.993 million, an increase of 33.47 percent
over the same period in 2021.
Revenues for January through July 2022 totaled
NT$ 324.509 million, an increase of 21.41 percent compared to
the NT$ 267.291 million for the same period in 2021.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Maxigen Biotech Inc. published this content on 09 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 August 2022 15:07:08 UTC.